B cells tell scleroderma fibroblasts to produce collagen

被引:19
作者
Daoussis, Dimitrios [1 ]
Liossis, Stamatis-Nick C. [1 ]
机构
[1] Patras Univ Hosp, Dept Internal Med, Div Rheumatol, Patras 26504, Greece
关键词
SYSTEMIC-SCLEROSIS; SKIN FIBROSIS; AUTOANTIBODIES; AUTOIMMUNITY; LYMPHOCYTES; EXPRESSION; RITUXIMAB; DEPLETION;
D O I
10.1186/ar4392
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In fibrosis fibroblasts are activated and overproduce collagen in a process with unknown drivers and equally unknown brakes that recently implicated a novel and surprising player, the B cell. B cells may be crucially involved in fibrosis in several ways: B cells may produce autoantibodies that can directly stimulate fibroblasts; B cells can produce profibrotic cytokines such as IL-6 or transforming growth factor beta; and, finally, B cells could directly stimulate fibroblasts by a contact-dependent mechanism. Recent experimental evidence suggests that B cells can enhance collagen production by fibroblasts, by a contact-dependent mechanism, and therefore are profibrotic ex vivo. These data strengthen the rationale of pursuing B-cell targeting therapies in systemic sclerosis.
引用
收藏
页数:3
相关论文
共 13 条
[1]  
ABRAHAM D, 1988, IMMUNOLOGY, V65, P385
[2]  
Baroni SS, 2006, NEW ENGL J MED, V354, P2667
[3]   Is There a Role for B-cell Depletion as Therapy for Scleroderma? A Case Report and Review of the Literature [J].
Daoussis, Dimitrios ;
Liossis, Stamatis-Nick C. ;
Tsamandas, Athanassios C. ;
Kalogeropoulou, Christina ;
Kazantzi, Alexandra ;
Korfiatis, Panagiotis ;
Yiannopoulos, Georgios ;
Andonopoulos, Andrew P. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2010, 40 (02) :127-136
[4]   Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study [J].
Daoussis, Dimitrios ;
Liossis, Stamatis-Nick C. ;
Tsamandas, Athanassios C. ;
Kalogeropoulou, Christina ;
Kazantzi, Alexandra ;
Sirinian, Chaido ;
Karampetsou, Maria ;
Yiannopoulos, Georgios ;
Andonopoulos, Andrew P. .
RHEUMATOLOGY, 2010, 49 (02) :271-280
[5]   B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis [J].
Francois, Antoine ;
Chatelus, Emmanuel ;
Wachsmann, Dominique ;
Sibilia, Jean ;
Bahram, Seiamak ;
Alsaleh, Ghada ;
Gottenberg, Jacques-Eric .
ARTHRITIS RESEARCH & THERAPY, 2013, 15 (05)
[6]   B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis [J].
Hasegawa, Minoru ;
Hamaguchi, Yasuhito ;
Yanaba, Koichi ;
Bouaziz, Jean-David ;
Uchida, Junji ;
Fujimoto, Manabu ;
Matsushita, Takashi ;
Matsushita, Yukiyo ;
Horikawa, Mayuka ;
Komura, Kazuhiro ;
Takehara, Kazuhiko ;
Sato, Shinichi ;
Tedder, Thomas F. .
AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (03) :954-966
[7]   B cell infiltration in systemic sclerosis-associated interstitial lung disease [J].
Lafyatis, Robert ;
O'Hara, Carl ;
Feghali-Bostwick, Carol A. ;
Matteson, Eric .
ARTHRITIS AND RHEUMATISM, 2007, 56 (09) :3167-3168
[8]   B Cell Depletion With Rituximab in Patients With Diffuse Cutaneous Systemic Sclerosis [J].
Lafyatis, Robert ;
Kissin, Eugene ;
York, Michael ;
Farina, Giuseppina ;
Viger, Kerry ;
Fritzler, Marvin J. ;
Merkel, Peter A. ;
Simms, Robert W. .
ARTHRITIS AND RHEUMATISM, 2009, 60 (02) :578-583
[9]   CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse [J].
Saito, E ;
Fujimoto, M ;
Hasegawa, M ;
Komura, K ;
Hamaguchi, Y ;
Koburagi, Y ;
Nagaoka, T ;
Takehara, K ;
Tedder, TF ;
Sato, S .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (11) :1453-1462
[10]   Altered blood B lymphocyte Homeostasis in systemic sclerosis - Expanded naive B cells and diminished but activated memory B cells [J].
Sato, S ;
Fujimoto, M ;
Hasegawa, M ;
Takehara, K .
ARTHRITIS AND RHEUMATISM, 2004, 50 (06) :1918-1927